{"organizations": [], "uuid": "6a4b86d7e950da2732ff2277d45ae1d45cf7b7d8", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.cnbc.com", "main_image": "", "site_section": "http://www.cnbc.com/id/10000551/device/rss", "section_title": "California", "url": "https://www.cnbc.com/2018/05/08/the-associated-press-sangamo-1q-earnings-snapshot.html", "country": "US", "domain_rank": 767, "title": "Sangamo: 1Q Earnings Snapshot", "performance_score": 0, "site": "cnbc.com", "participants_count": 1, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-05-08T15:17:00.000+03:00", "replies_count": 0, "uuid": "6a4b86d7e950da2732ff2277d45ae1d45cf7b7d8"}, "author": "cnbc.com", "url": "https://www.cnbc.com/2018/05/08/the-associated-press-sangamo-1q-earnings-snapshot.html", "ord_in_thread": 0, "title": "Sangamo: 1Q Earnings Snapshot", "locations": [], "entities": {"persons": [], "locations": [{"name": "richmond", "sentiment": "none"}, {"name": "calif.", "sentiment": "none"}, {"name": "richmond", "sentiment": "none"}], "organizations": [{"name": "sangamo therapeutics inc.", "sentiment": "negative"}, {"name": "sangamo", "sentiment": "negative"}, {"name": "ap", "sentiment": "negative"}, {"name": "zacks investment research", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "RICHMOND, Calif. (AP) _ Sangamo Therapeutics Inc. (SGMO) on Tuesday reported a loss of $20.2 million in its first quarter.\nOn a per-share basis, the Richmond, California-based company said it had a loss of 23 cents.\nThe results fell short of Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for earnings of 29 cents per share.\nThe drug developer posted revenue of $12.6 million in the period.\nSangamo shares have decreased nearly 1 percent since the beginning of the year. The stock has more than tripled in the last 12 months.\nThis story was generated by Automated Insights ( http://automatedinsights.com/ap ) using data from Zacks Investment Research. Access a Zacks stock report on SGMO at https://www.zacks.com/ap/SGMO", "external_links": ["https://www.zacks.com/ap/SGMO", "http://automatedinsights.com/ap"], "published": "2018-05-08T15:17:00.000+03:00", "crawled": "2018-05-08T17:09:02.012+03:00", "highlightTitle": ""}